Copyright
©The Author(s) 2017.
World J Gastroenterol. Mar 7, 2017; 23(9): 1568-1575
Published online Mar 7, 2017. doi: 10.3748/wjg.v23.i9.1568
Published online Mar 7, 2017. doi: 10.3748/wjg.v23.i9.1568
Figure 4 Hypermethylation at hsa-miR-183 significantly correlates with worse survival in hepatocellular carcinoma.
The Kaplan-Meier plot shows comparison of HCC patient survival between those with hypermethylated and non-methylated hsa-miR-183 locus (log-rank test P = 0.03, median survivals are 49.5 and 150 wk for patients with hypermethylation and without increased methylation at hsa-miR-183 locus respectively). HCC: Hepatocellular carcinoma.
- Citation: Anwar SL, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, Kreipe H, Buurman R, Skawran B, Lehmann U. hsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinoma. World J Gastroenterol 2017; 23(9): 1568-1575
- URL: https://www.wjgnet.com/1007-9327/full/v23/i9/1568.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i9.1568